SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:SRLS
CUSIPN/A
Phone+1-508-2446400
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
SeraCare Life Sciences (NASDAQ:SRLS) Frequently Asked Questions
What is SeraCare Life Sciences' stock symbol?
SeraCare Life Sciences trades on the NASDAQ under the ticker symbol "SRLS."
Has SeraCare Life Sciences been receiving favorable news coverage?
News headlines about SRLS stock have been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. SeraCare Life Sciences earned a news impact score of 0.16 on Accern's scale. They also gave media stories about the company an impact score of 47.89 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for SeraCare Life Sciences.
How do I buy shares of SeraCare Life Sciences?
Shares of SRLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact SeraCare Life Sciences?
SeraCare Life Sciences' mailing address is 37 Birch St, MILFORD, MA 01757-5501, United States. The company can be reached via phone at +1-508-2446400.
MarketBeat Community Rating for SeraCare Life Sciences (NASDAQ SRLS)
MarketBeat's community ratings are surveys of what our community members think about SeraCare Life Sciences and other stocks. Vote "Outperform" if you believe SRLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
